12900 Results (Page 257 of 516)
All Market Research Reports
Brazil Digital Therapeutics Market Analysis
Brazil Digital Therapeutics Market is at around $0.16 Bn in 2023 and is projected to reach $0.89 Bn in 2030, exhibiting a CAGR of 28.2% during the forecast period. The market is expanding due to rising awareness and acceptance, technological advancements, and government policies and directives. The market is dominated by key players like Dr. Consulta, Pixeon, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
Mexico Allergy Therapeutics Market Analysis
Mexico Allergy Therapeutics Market was valued at $348 Mn in 2022 and is estimated to reach $582 Mn in 2030, exhibiting a CAGR of 6.65% during the forecast period. The market for allergy treatment medications is expanding as a result of the rising incidence of allergic illnesses and associated health problems. The top leading pharmaceutical companies operating in the market are GlaxoSmithKline, Sanofi, Merck & Co., Novartis, Bayer, Johnson & Johnson, Teva Pharmaceutical Industries, Valeant Pharmaceuticals International, Grupo farmacéutico Sanfer and Genomma Laboratorios.
Malaysia Allergy Therapeutics Market Analysis
Malaysia Allergy Therapeutics Market was valued at $37 Mn in 2022 and is estimated to reach $62 Mn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The increased incidence of allergic illnesses and associated health issues is driving the need for allergy therapy medications. The major pharmaceutical players that are presently functioning in the market are GlaxoSmithKline, Sanofi, Novartis, Bayer, AstraZeneca, Eisai Co., Takeda Pharmaceutical Company, Pharmaniaga Berhad, Duopharma Biotech Bhd and Reckitt Benckiser.
Kenya Allergy Therapeutics Market Analysis
Kenya Allergy Therapeutics Market was valued at $16 Mn in 2022 and is estimated to reach $29 Mn in 2030, exhibiting a CAGR of 7.5% during the forecast period. The growing numbers of allergic disorders and associated health problems is driving up the need for allergy treatment drugs. GlaxoSmithKline, Novartis, Sanofi, AstraZeneca, Bayer, Pfizer, Abbott, Pharmanet Kenya Ltd., Mepharm Kenya Ltd. and Mediheal Kenya Ltd. are top leading pharmaceutical companies that are currently operating in the market.
Japan Allergy Therapeutics Market Analysis
Japan Allergy Therapeutics Market was valued at $1442 Mn in 2022 and is estimated to reach $2459 Mn in 2030, exhibiting a CAGR of 6.9% during the forecast period. The increased incidence of allergic illnesses and associated health issues is driving the need for allergy therapy medications. The major pharmaceutical players that are presently functioning in the market are Eisai Co., Takeda Pharmaceutical Company Limited, Novartis AG, Sanofi, GlaxoSmithKline (GSK), AstraZeneca, Mitsubishi Tanabe Pharma Corporation, Shionogi & Co., Kowa Pharmaceutical Co., and Daiichi Sankyo Co.
Indonesia Allergy Therapeutics Market Analysis
Indonesia Allergy Therapeutics Market was valued at $139 Mn in 2022 and is estimated to reach $229 Mn in 2030, exhibiting a CAGR of 6.4% during the forecast period. The need for allergy treatment drugs is being driven by the rising prevalence of allergic disorders and related health problems. Sanofi, Novartis, Boehringer Ingelheim, GlaxoSmithKline (GSK), AstraZeneca, Abbott Laboratories, Bayer, PT Kalbe Farma, PT Pharos Indonesia and PT Sanbe Farma are the leading pharmaceutical companies that are presently operating in the market
Germany Allergy Therapeutics Market Analysis
Germany Allergy Therapeutics Market was valued at $849 Mn in 2022 and is estimated to reach $1217 Mn in 2030, exhibiting a CAGR of 4.6% during the forecast period. The growing demand for pharmaceutical allergy therapeutics is being driven by the rising incidence of allergic diseases and associated health issues. The major pharmaceutical companies that are presently performing in the market are Novartis, GlaxoSmithKline (GSK), Sanofi, Roche, Merck & Co., Johnson & Johnson, AstraZeneca, Bayer, Boehringer Ingelheim and Allergan
France Allergy Therapeutics Market Analysis
France Allergy Therapeutics Market was valued at $638 Mn in 2022 and is estimated to reach $972 Mn in 2030, exhibiting a CAGR of 5.4% during the forecast period. The growing prevalence of allergic disorders and related health issues is driving the demand for allergy treatment pharmaceuticals. The top leading pharmaceutical companies operating in the market are Sanofi, Novartis, GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Johnson & Johnson, Roche, Teva Pharmaceutical Industries, ALK-Abelló and Stallergenes Greer.
Egypt Allergy Therapeutics Market Analysis
Egypt Allergy Therapeutics Market was valued at $65 Mn in 2022 and is estimated to reach $119 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The need for allergy treatment medications is rising due to the frequency of allergic illnesses and related health issues. The top pharmaceutical companies that are currently operating in the market are Novartis, Sanofi, Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck & Co., Bayer, AstraZeneca, Roche and Teva Pharmaceutical Industries.
China Allergy Therapeutics Market Analysis
China Allergy Therapeutics Market was valued at $1865 Mn in 2022 and is estimated to reach $3426 Mn in 2030, exhibiting a CAGR of 7.9% during the forecast period. The need for allergy treatment drugs is being driven by the rising prevalence of allergic disorders and the related health problems. Jiangsu Hengrui Medicine Co., BeiGene, CSPC Pharmaceutical Group Co., Yunnan Baiyao Group Co., Sinopharm Group Co., Guangzhou Fuluo Pharmaceutical Co., Hunan Haier Pharmaceutical Co., Shandong Lukang Pharmaceutical Group Co., North China Pharmaceutical Group Corporation and Shanghai RAAS Pharma Co. are the leading pharmaceutical companies that are presently operating in the market
Canada Allergy Therapeutics Market Analysis
Canada Allergy Therapeutics Market was valued at $1856 Mn in 2022 and is estimated to reach $3049 Mn in 2030, exhibiting a CAGR of 6.4% during the forecast period. The rising incidence of allergic diseases and associated illnesses is a major market driver for the expansion of the allergy therapeutics market. Some of the leading pharmaceutical companies operating in the market are Sanofi, Novartis, GlaxoSmithKline (GSK), AstraZeneca, Merck & Co., Johnson & Johnson, Roche, Teva Pharmaceutical Industries, ALK-Abelló, and Stallergenes Greer
Brazil Allergy Therapeutics Market Analysis
Brazil Allergy Therapeutics Market was valued at $580 Mn in 2022 and is estimated to reach $1027 Mn in 2030, exhibiting a CAGR of 7.4% during the forecast period. The growing prevalence of allergic disorders and related medical issues is driving growth in the market for allergy treatment drugs. The top leading pharmaceutical companies operating in the market are GlaxoSmithKline (GSK), Sanofi, Merck & Co., Novartis, Bayer, Johnson & Johnson, Teva Pharmaceutical Industries, Chiesi Farmaceutici, Eurofarma Laboratórios and EMS.
Vietnam Alcohol Addiction Therapeutics Market Analysis
The Vietnam Alcohol Addiction Therapeutics Market is valued at around $4 Mn in 2022 and is projected to reach $6 Mn by 2030, exhibiting a CAGR of 6.53% during the forecast period. The market drivers in the Vietnam Alcohol Addiction Therapeutic Market include factors like rising harmful alcohol use among the 18–29 age group, increased recognition of alcohol addiction as a treatable mental health issue, and growing demand for therapeutic innovation in addiction therapy. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Vietnam are Abbott, Pfizer, AstraZeneca, Roche, Lundbeck, Traphaco, Hau Giang Pharmaceuticals, Bidipharm Pharmaceuticals, Stada Vietnam, Mylan Laboratories, etc., among others.
US Alcohol Addiction Therapeutics Market Analysis
The US Alcohol Addiction Therapeutics Market is valued at around $301 Mn in 2022 and is projected to reach $421 Mn by 2030, exhibiting a CAGR of 4.3% during the forecast period. The market is driven by a mix of factors, such as the increasing prevalence of alcohol addiction in the US, the presence of promising drugs in the pipeline and increased coverage of therapeutics by insurance providers. The key players involved in the research, development and distribution of Alcohol Addiction Therapeutics in US are Alkermes, TEVA, GlaxoSmithKline, Lundbeck, Eli Lilly, BioCorRx, Chronos, AstraZeneca, Roche, Opiant Pharmaceuticals, etc among others
UK Alcohol Addiction Therapeutics Market Analysis
The UK Alcohol Addiction Therapeutics Market is valued at around $19 Mn in 2022 and is projected to reach $26 Mn by 2030, exhibiting a CAGR of 4.3% during the forecast period. The major growth drivers of the UK alcohol addiction therapeutics market lie in the transition towards personalized treatment approaches, an evolving policy landscape, and a shifting focus on social determinants, expanding engagement with social welfare groups and community activities to address the multifaceted aspects of alcoholism. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in UK are Elli Lily, Roche, AbbVie, Lundbeck, Alkermes, Otsuka Pharmaceuticals, Hikma Pharmaceuticals, Pfizer, BioCorRx, Ethypharm, etc among others
UAE Alcohol Addiction Therapeutics Market Analysis
The UAE Alcohol Addiction Therapeutics Market is valued at around $4 Mn in 2022 and is projected to reach $6 Mn by 2030, exhibiting a CAGR of 7.3% during the forecast period. The UAE Alcohol Addiction Therapeutic Market's market drivers include growing urbanization, social pressures in the workplace, and increased awareness of mental health problems, all of which contribute to increased alcohol intake. The key players involved in the research, development and distribution of Alcohol Addiction Therapeutics in UAE are GlaxoSmithKline, Lundbeck, TEVA, Roche, Eli Lilly, AstraZeneca, Cipla, Pfizer, Camden, Sun Pharmaceuticals, etc among others
Spain Alcohol Addiction Therapeutics Market Analysis
The Spain Alcohol Addiction Therapeutics Market is valued at around $14 Mn in 2022 and is projected to reach $21 Mn by 2030, exhibiting a CAGR of 5.3% during the forecast period. The primary growth drivers of the Spain alcohol addiction therapeutics market are government-supported initiatives promoting addiction treatment and harm reduction, as well as an increasing prevalence of alcohol use, demographic trends, and the incorporation of innovative technologies to improve accessibility and flexibility in treatment approaches. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Spain are Elli Lily, Roche, AbbVie, Lundbeck, Alkermes, Otsuka Pharmaceuticals, Janssen, Kern Pharma, Ferrer, Esteve etc among others
South Africa Alcohol Addiction Therapeutics Market Analysis
The South Africa Alcohol Addiction Therapeutics Market is valued at around $5 Mn in 2022 and is projected to reach $8 Mn by 2030, exhibiting a CAGR of 7.53% during the forecast period. Major drivers in the South Africa Alcohol Addiction Therapeutics Market include increased research into newer treatment options, demand for comprehensive therapy that includes non-pharmaceutical interventions, and a rising incidence of alcohol use driven by high rates, economic challenges, and mental health disorders. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in South Africa are Alkermes, Aspen Healthcare, Pfizer, Teva Pharmaceuticals, Addex Therapeutics, Opiant Pharmaceuticals, GlaxoSmithKline (GSK), EthyPharm, Merck & Co., Otsuka, etc., among others.
Singapore Alcohol Addiction Therapeutics Market Analysis
The Singapore Alcohol Addiction Therapeutics Market is valued at around $0.86 Mn in 2022 and is projected to reach $1.46 Mn by 2030, exhibiting a CAGR of 6.9% during the forecast period. Market drivers in the Singapore Alcohol Addiction Therapeutics Market are influenced by factors like evolving treatments, private sector engagement, and a rising prevalence of alcohol-related issues among young individuals. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Singapore are Lundbeck, Otsuka Pharmaceuticals, AbbVie, Alkarmes, BioMarin, Pfizer, Mylan, Eli Lilly, AstraZeneca, GlaxoSmithKline (GSK) etc among others
Saudi Arabia Alcohol Addiction Therapeutics Market Analysis
The Saudi Arabia Alcohol Addiction Therapeutics Market is valued at around $12 Mn in 2022 and is projected to reach $22 Mn by 2030, exhibiting a CAGR of 7.8% during the forecast period. The Therapeutics Sector is facing an expanding market opportunity due to the changing demographic landscape, with younger people who are more exposed to global trends and have more disposable income, as well as increased awareness of alcoholism as a treatable disorder and limited treatment options in Saudi Arabia. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Saudi Arabia are GlaxoSmithKline, Lundbeck, TEVA, Roche, Eli Lilly, AstraZeneca, Cipla, Naseej, Taamer, Sun Pharmaceuticals, etc among others
Philippines Alcohol Addiction Therapeutics Market Analysis
The Philippines Alcohol Addiction Therapeutics Market is valued at around $2 Mn in 2022 and is projected to reach $3 Mn by 2030, exhibiting a CAGR of 6.8% during the forecast period. The drivers of the Philippines Alcohol Addiction Therapeutics Market include urbanization-related stress, higher disposable income for healthcare, government mental health initiatives and policies, and an evolving healthcare landscape with expanded coverage and improved accessibility through telemedicine and digital health solutions. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in the Philippines are Lundbeck, Roche, Eli Lilly, AstraZeneca, GlaxoSmithKline (GSK), BioCorRx, Generika, Unilab, Medco, PhilPharma etc among others.
Mexico Alcohol Addiction Therapeutics Market Analysis
The Mexico Alcohol Addiction Therapeutics Market is valued at around $11 Mn in 2022 and is projected to reach $18 Mn by 2030, exhibiting a CAGR of 6.55% during the forecast period. The market is fueled by drivers such as increasing prevalence, an increase in the efforts taken by the government to battle addiction, and the adoption of newer advanced technologies by the general population. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Mexico are Elli Lily, Roche, AbbVie, TEVA, Otsuka Pharmaceuticals, GlaxoSmithKline, Johnson & Jhonson, Viatris, Grupo Ferrer and Genomma, among various others
Malaysia Alcohol Addiction Therapeutics Market Analysis
The Malaysia Alcohol Addiction Therapeutics Market is valued at around $1 Mn in 2022 and is projected to reach $2 Mn by 2030, exhibiting a CAGR of 6.5% during the forecast period. In Malaysia, market growth for alcohol addiction treatment is driven by heightened government involvement, a holistic approach to therapy, and improved accessibility due to economic growth, increased disposable incomes, and expanded insurance coverage and government-funded programs. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Malaysia are Lundbeck, Roche, AstraZeneca, Alkermes, TEVA Pharmaceuticals, Pfizer, BioCorRx, Otsuka, Pharmaniaga, DuoPharma Biotech etc among others
Kenya Alcohol Addiction Therapeutics Market Analysis
The Kenya Alcohol Addiction Therapeutics Market is valued at around $5 Mn in 2022 and is projected to reach $8 Mn by 2030, exhibiting a CAGR of 7.5% during the forecast period. The increasing prevalence of alcohol use, increased awareness and destigmatization efforts along with the development of healthcare infrastructure, as well as the government initiatives to integrate and improve AUD treatment within primary healthcare services are all factors driving the Kenya Alcohol Addiction Therapeutic Market. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Kenya are Alkermes, Teva Pharmaceuticals, BioCorRx, Adial Pharmaceuticals, Addex Therapeutics, Opiant Pharmaceuticals, GlaxoSmithKline (GSK), Merck & Co., Kinnov Therapeutics, Omeros Corporation etc among others.
Japan Alcohol Addiction Therapeutics Market Analysis
The Japan Alcohol Addiction Therapeutics Market is valued at around $44 Mn in 2022 and is projected to reach $75 Mn by 2030, exhibiting a CAGR of 6.8% during the forecast period. Japan's market growth is propelled by government acknowledgment, increased mental health funding, and a rising demand for more effective and tolerable novel therapies to address the challenges posed by alcohol misuse in an aging population. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Japan are Lundbeck, AstraZeneca, Alkermes, Merck & Co., TEVA Pharmaceuticals, Pfizer, BioCorRx, Otsuka, Kyorin, Eisai etc among others.